About Bactiguard

Bactiguard is a Swedish medical device company with a mission to increase patient safety and save lives. To achieve this mission, we develop and supply infection prevention solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we reduce patient suffering and hospital stays and thereby save significant resources and costs for the healthcare system and society at large​

The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. The technology is offered through license agreements with other medical device manufacturers and our proprietary BIP (Bactiguard Infection Protection) portfolio of products. Through our license partner BD (Becton, Dickinson and Company) following their acquisition of C.R. Bard, urinary catheters with Bactiguard’s coating are market leading in the USA and Japan. Bactiguard’s own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract.

Bactiguard is in a strong expansion phase in Europe, China, India and the Middle East as well as by establishing license agreements in new therapeutic areas. The company has some 70 employees around the world. The headquarter and one of two production sites are located in Stockholm, the other one in Malaysia. Bactiguard is listed on Nasdaq Stockholm since 2014.

About Bactiguard
About Bactiguard